IL10RB and B-cell chronic lymphocytic leukemia: Of interest, Il10rb-deficient CD4+ T cells showed a reduced control of CLL as measured by higher CD5+ CD19+ CLL counts in blood over time and by higher spleen weights 4 weeks after TCL1 AT in comparison to control mice receiving WT T cells (Fig. 6A).